{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:49:07Z","timestamp":1788965347295,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"DOI":"10.7759\/cureus.106772","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:01:44Z","timestamp":1775818904000},"source":"Crossref","is-referenced-by-count":1,"title":["Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Glucose Transporter 1 (GLUT-1) as Predictors of Insulin Resistance in Patients With Rheumatoid Arthritis: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Diptimayee","family":"Upadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashree","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh Kumar","family":"Bhola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswini Kumar","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minushree","family":"Pasayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florina","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200435","article-title":"Higher prevalence and degree of insulin resistance in patients with rheumatoid arthritis than in patients with systemic lupus erythematosus","volume":"48","author":"Quevedo-Abeledo JC","year":"2021","unstructured":"Quevedo-Abeledo JC, S\u00e1nchez-P\u00e9rez H, Tejera-Segura B, et al.. Higher prevalence and degree of insulin resistance in patients with rheumatoid arthritis than in patients with systemic lupus erythematosus. J Rheumatol. 2021, 48:339-47. 10.3899\/jrheum.200435","journal-title":"J Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1654988","article-title":"Changes in serum adipokines profile and insulin resistance in patients with rheumatoid arthritis treated with anti-TNF-\u03b1","volume":"35","author":"Corrado A","year":"2019","unstructured":"Corrado A, Colia R, Rotondo C, Sanpaolo E, Cantatore FP. Changes in serum adipokines profile and insulin resistance in patients with rheumatoid arthritis treated with anti-TNF-\u03b1. Curr Med Res Opin. 2019, 35:2197-205. 10.1080\/03007995.2019.1654988","journal-title":"Curr Med Res Opin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.07.002","article-title":"Serum retinol-binding protein 4 is associated with insulin resistance in patients with early and untreated rheumatoid arthritis","volume":"86","author":"Wei Y","year":"2019","unstructured":"Wei Y, Xia N, Zhang W, et al.. Serum retinol-binding protein 4 is associated with insulin resistance in patients with early and untreated rheumatoid arthritis. Joint Bone Spine. 2019, 86:335-41. 10.1016\/j.jbspin.2018.07.002","journal-title":"Joint Bone Spine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0982-5","article-title":"A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls","volume":"18","author":"Bartlett DB","year":"2016","unstructured":"Bartlett DB, Connelly MA, AbouAssi H, et al.. A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls. Arthritis Res Ther. 2016, 18:10.1186\/s13075-016-0982-5","journal-title":"Arthritis Res Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112998","article-title":"Adipokines in rheumatoid arthritis: emerging biomarkers and therapeutic targets","volume":"11","author":"Bilski J","year":"2023","unstructured":"Bilski J, Schramm-Luc A, Szczepanik M, et al.. Adipokines in rheumatoid arthritis: emerging biomarkers and therapeutic targets. Biomedicines. 2023, 11:10.3390\/biomedicines11112998","journal-title":"Biomedicines"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1077166","article-title":"Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques","volume":"13","author":"Bolla E","year":"2023","unstructured":"Bolla E, Tentolouris N, Sfikakis PP, Tektonidou MG. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques. Front Immunol. 2023, 13:10.3389\/fimmu.2022.1077166","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000044554","article-title":"The neutrophil-to-lymphocyte ratio in rheumatoid arthritis: the dual perspectives from literature and clinic","volume":"104","author":"Li Y","year":"2025","unstructured":"Li Y, Liu J, Hu Y, Cong C, Chen Y, Fang Y. The neutrophil-to-lymphocyte ratio in rheumatoid arthritis: the dual perspectives from literature and clinic. Medicine. 2025, 104:10.1097\/MD.0000000000044554","journal-title":"Medicine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2018.1061","article-title":"Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis","volume":"70","author":"Bellan M","year":"2018","unstructured":"Bellan M, Bor S, Gibbin A, et al.. Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis. Reumatismo. 2018, 70:232-40. 10.4081\/reumatismo.2018.1061","journal-title":"Reumatismo"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194962","article-title":"Pharmacological targeting of GLUT1 to control autoreactive T cell responses","volume":"20","author":"Di Dedda C","year":"2019","unstructured":"Di Dedda C, Vignali D, Piemonti L, Monti P. Pharmacological targeting of GLUT1 to control autoreactive T cell responses. Int J Mol Sci. 2019, 20:10.3390\/ijms20194962","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.38986","article-title":"Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis","volume":"67","author":"Giles JT","year":"2015","unstructured":"Giles JT, Danielides S, Szklo M, et al.. Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis. Arthritis Rheumatol. 2015, 67:626-36. 10.1002\/art.38986","journal-title":"Arthritis Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.899372","article-title":"Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes","volume":"13","author":"Frazzei G","year":"2022","unstructured":"Frazzei G, van Vollenhoven RF, de Jong BA, Siegelaar SE, van Schaardenburg D. Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes. Front Immunol. 2022, 13:10.3389\/fimmu.2022.899372","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231164548","article-title":"Insulin resistance and cardiovascular disease","volume":"51","author":"Kosmas CE","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. J Int Med Res. 2023, 51:10.1177\/03000605231164548","journal-title":"J Int Med Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2024.103001","article-title":"The effects of anti-TNF-\u03b1 biologics on insulin resistance and insulin sensitivity in patients with rheumatoid arthritis: an update systematic review and meta-analysis","volume":"18","author":"Lim WS","year":"2024","unstructured":"Lim WS, Teoh SE, Tang AS, et al.. The effects of anti-TNF-\u03b1 biologics on insulin resistance and insulin sensitivity in patients with rheumatoid arthritis: an update systematic review and meta-analysis. Diabetes Metab Syndr. 2024, 18:10.1016\/j.dsx.2024.103001","journal-title":"Diabetes Metab Syndr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.13107\/jocr.2025.v15.i04.5526","article-title":"Effect of DMARD therapy on inflammatory biomarkers and disease activity in rheumatoid arthritis patients","volume":"15","author":"Kharbanda H","year":"2025","unstructured":"Kharbanda H, Khanna M, Thakrar K, Basak M, Dwivedi M, Das PP. Effect of DMARD therapy on inflammatory biomarkers and disease activity in rheumatoid arthritis patients. J Orthop Case Rep. 2025, 15:299-305. 10.13107\/jocr.2025.v15.i04.5526","journal-title":"J Orthop Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03249-7","article-title":"The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients with comorbid type 2 diabetes: a proof-of-concept, open, prospective, clinical study","volume":"26","author":"Di Muzio C","year":"2024","unstructured":"Di Muzio C, Di Cola I, Panahi AS, et al.. The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients with comorbid type 2 diabetes: a proof-of-concept, open, prospective, clinical study. Arthritis Res Ther. 2024, 26:10.1186\/s13075-023-03249-7","journal-title":"Arthritis Res Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2016.09.001","article-title":"Rheumatoid arthritis, insulin resistance, and diabetes","volume":"84","author":"Nicolau J","year":"2017","unstructured":"Nicolau J, Lequerr\u00e9 T, Bacquet H, Vittecoq O. Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine. 2017, 84:411-6. 10.1016\/j.jbspin.2016.09.001","journal-title":"Joint Bone Spine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-023-02786-8","article-title":"Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis","volume":"408","author":"Portale G","year":"2023","unstructured":"Portale G, Bartolotta P, Azzolina D, Gregori D, Fiscon V. Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis. Langenbecks Arch Surg. 2023, 408:10.1007\/s00423-023-02786-8","journal-title":"Langenbecks Arch Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2120472","article-title":"A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality","volume":"18","author":"Zinellu A","year":"2022","unstructured":"Zinellu A, Mangoni AA. A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality. Expert Rev Clin Immunol. 2022, 18:1187-202. 10.1080\/1744666X.2022.2120472","journal-title":"Expert Rev Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02905-8","article-title":"Downregulation of the glucose transporter GLUT 1 in the cerebral microvasculature contributes to postoperative neurocognitive disorders in aged mice","volume":"20","author":"Chen Y","year":"2023","unstructured":"Chen Y, Joo J, Chu JM, Chang RC, Wong GT. Downregulation of the glucose transporter GLUT 1 in the cerebral microvasculature contributes to postoperative neurocognitive disorders in aged mice. J Neuroinflammation. 2023, 20:10.1186\/s12974-023-02905-8","journal-title":"J Neuroinflammation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8218","article-title":"Glucose transporter\u20111 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells","volume":"47","author":"Shima T","year":"2022","unstructured":"Shima T, Taniguchi K, Tokumaru Y, et al.. Glucose transporter\u20111 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells. Oncol Rep. 2022, 47:10.3892\/or.2021.8218","journal-title":"Oncol Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5146\/tjpath.2021.01557","article-title":"GLUT-1 expression in breast cancer","volume":"38","author":"Okcu O","year":"2022","unstructured":"Okcu O, Sen B, Ozturk C, Guvendi GF, Bedir R. GLUT-1 expression in breast cancer. Turk Patoloji Derg. 2022, 38:114-21. 10.5146\/tjpath.2021.01557","journal-title":"Turk Patoloji Derg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.984408","article-title":"Solute carrier nutrient transporters in rheumatoid arthritis fibroblast-like synoviocytes","volume":"13","author":"Torres A","year":"2022","unstructured":"Torres A, Pedersen B, Guma M. Solute carrier nutrient transporters in rheumatoid arthritis fibroblast-like synoviocytes. Front Immunol. 2022, 13:10.3389\/fimmu.2022.984408","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114463","article-title":"Design, synthesis of novel triptolide-glucose conjugates targeting glucose transporter-1 and their selective antitumor effect","volume":"238","author":"Liu Y","year":"2022","unstructured":"Liu Y, Huang J, Wu M, et al.. Design, synthesis of novel triptolide-glucose conjugates targeting glucose transporter-1 and their selective antitumor effect. Eur J Med Chem. 2022, 238:10.1016\/j.ejmech.2022.114463","journal-title":"Eur J Med Chem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.02.015","article-title":"The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming","volume":"34","author":"Hochrein SM","year":"2022","unstructured":"Hochrein SM, Wu H, Eckstein M, et al.. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 2022, 34:516-32. 10.1016\/j.cmet.2022.02.015","journal-title":"Cell Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: mechanisms and interventions","volume":"9","author":"Hu T","year":"2024","unstructured":"Hu T, Liu CH, Lei M, Zeng Q, Li L, Tang H, Zhang N. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct Target Ther. 2024, 9:10.1038\/s41392-024-01954-6","journal-title":"Signal Transduct Target Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.4.290","article-title":"Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide","volume":"61","author":"Emery P","year":"2002","unstructured":"Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis. 2002, 61:290-7. 10.1136\/ard.61.4.290","journal-title":"Ann Rheum Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh199","article-title":"Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis","volume":"43","author":"Nell VP","year":"2004","unstructured":"Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology. 2004, 43:906-14. 10.1093\/rheumatology\/keh199","journal-title":"Rheumatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/474500-neutrophil-to-lymphocyte-ratio-platelet-to-lymphocyte-ratio-and-glucose-transporter-1-glut-1-as-predictors-of-insulin-resistance-in-patients-with-rheumatoid-arthritis-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:01:45Z","timestamp":1775818905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/474500-neutrophil-to-lymphocyte-ratio-platelet-to-lymphocyte-ratio-and-glucose-transporter-1-glut-1-as-predictors-of-insulin-resistance-in-patients-with-rheumatoid-arthritis-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.106772","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,10]]}}}